Atrys Health, S.A. (ATRY.MC)

EUR 3.11

(0.32%)

Market Cap (In EUR)

236.16 Million

Revenue (In EUR)

201.56 Million

Net Income (In EUR)

-45.59 Million

Avg. Volume

17.22 Thousand

Currency
EUR
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
2.77-4.48
PE
-
EPS
-
Beta Value
0.561
ISIN
ES0105148003
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Ms. Isabel Lozano Fernandez
Employee Count
-
Website
https://www.atryshealth.com
Ipo Date
2016-07-22
Details
Atrys Health, S.A., a biomedical company, provides diagnostic services and medical treatments. The company offers diagnostic services in the fields of pathology, hematology, molecular pathology, and genetics; and diagnostic second opinion, test directory, and clinical trials and R&D services. It uses telemedicine to provide its services in the medical specialties of radiology, cardiology, ophthalmology, and dermatology. The company also provides radiotherapy; and develops therapeutic modalities and diagnostic tools. The company was formerly known as Althia Health, S.L. and changed its name to Atrys Health, S.A. in May 2016. Atrys Health, S.A. was incorporated in 2007 and is headquartered in Madrid, Spain.